Page last updated: 2024-10-31

midodrine and Weight Reduction

midodrine has been researched along with Weight Reduction in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites."9.19Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014)
"The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites."5.19Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, A1
Farid, S1
Amin, M1
Kassem, M1
Al-Garem, N1

Trials

1 trial available for midodrine and Weight Reduction

ArticleYear
Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
    Hepato-gastroenterology, 2014, Volume: 61, Issue:135

    Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Ascites; Blood Flow Velocity; Double-Blind Method; Drain

2014